GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
23.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer. |
---|---|
AbstractList | The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer. |
Author | CHENG, Seng, H LEONARD, John XIANG, Yibin NATOLI, Thomas HIRTH, Bradford CELATKA, Cassandra JANCSICS, Katherine GOOD, Andrew SCHEULE, Ronald, K MARSHALL, John BOURQUE, Elyse ZHAO, Zhong MAKINO, Elina SKERLJ, Renato BESKROVNAYA, Oxana METZ, Markus CABRERA-SALAZAR, Mario, A HUSSON, Herve |
Author_xml | – fullname: BESKROVNAYA, Oxana – fullname: CELATKA, Cassandra – fullname: XIANG, Yibin – fullname: LEONARD, John – fullname: BOURQUE, Elyse – fullname: SKERLJ, Renato – fullname: MAKINO, Elina – fullname: METZ, Markus – fullname: NATOLI, Thomas – fullname: GOOD, Andrew – fullname: CABRERA-SALAZAR, Mario, A – fullname: HIRTH, Bradford – fullname: CHENG, Seng, H – fullname: SCHEULE, Ronald, K – fullname: HUSSON, Herve – fullname: MARSHALL, John – fullname: ZHAO, Zhong – fullname: JANCSICS, Katherine |
BookMark | eNrjYmDJy89L5WRQcfcJdfYPjvRxdg1y9PV0cVUIjvQL8XAMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BRhaWpiYWJk6GxkQoAQBFsSTZ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | GLUCOSYLCERAMID-SYNTHASE-HEMMER INHIBITEURS DE SYNTHASE DE GLUCOSYLCÉRAMIDE |
ExternalDocumentID | EP2895484B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP2895484B13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 23 06:55:33 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP2895484B13 |
Notes | Application Number: EP20130765893 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&CC=EP&NR=2895484B1 |
ParticipantIDs | epo_espacenet_EP2895484B1 |
PublicationCentury | 2000 |
PublicationDate | 20220223 |
PublicationDateYYYYMMDD | 2022-02-23 |
PublicationDate_xml | – month: 02 year: 2022 text: 20220223 day: 23 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | Genzyme Corporation |
RelatedCompanies_xml | – name: Genzyme Corporation |
Score | 3.391003 |
Snippet | The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&locale=&CC=EP&NR=2895484B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTaxSEw0NgctajcDdlASTZJ0Lc2TUnQtUpJBZ5UYpaYlgRfI-pl5hJp4RZhGMDFkwvbCgM8JLQcfjgjMUcnA_F4CLq8LEINYLuC1lcX6SZlAoXx7txBbFzVo79gIhIzVXJxsXQP8Xfyd1ZydgSw1vyBbYL8C2DY3cQJ2lFhBrWjQMfuuYU6gTSkFyDWKmyADWwDQsLwSIQam1DxhBk5n2MVrwgwcvtD5biATmvWKRRhU3H1Cnf2DI32cXYMcfT1dXBWCI_1CPByDXRU8_Tw8nTxD_IOCRRkU3FxDnD10gdbFw70W7xoAd5ixGAMLsMefKsGgYJkGOi7WwCDJyDDVxCTZ0CLZLMnQINHCDFgdp1qkmEoySOI0RgqPnDQDFyiAwDuyjWUYWEqKSlNlgXVqSZIcODQA_8h2zQ |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTaxSEw0NgctajcDdlASTZJ0Lc2TUnQtUpJBZ5UYpaYlgRfI-pl5hJp4RZhGMDFkwvbCgM8JLQcfjgjMUcnA_F4CLq8LEINYLuC1lcX6SZlAoXx7txBbFzVo79gIhIzVXJxsXQP8Xfyd1ZydgSw1vyBbYL8C2DY3cQJ2lFjNQYfzglpOYU6gTSkFyDWKmyADWwDQsLwSIQam1DxhBk5n2MVrwgwcvtD5biATmvWKRRhU3H1Cnf2DI32cXYMcfT1dXBWCI_1CPByDXRU8_Tw8nTxD_IOCRRkU3FxDnD10gdbFw70W7xoAd5ixGAMLsMefKsGgYJkGOi7WwCDJyDDVxCTZ0CLZLMnQINHCDFgdp1qkmEoySOI0RgqPnDwDp0eIr0-8j6eftzQDFyiwwLuzjWUYWEqKSlNlgfVrSZIcOGQAtiF5ug |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=GLUCOSYLCERAMIDE+SYNTHASE+INHIBITORS&rft.inventor=BESKROVNAYA%2C+Oxana&rft.inventor=CELATKA%2C+Cassandra&rft.inventor=XIANG%2C+Yibin&rft.inventor=LEONARD%2C+John&rft.inventor=BOURQUE%2C+Elyse&rft.inventor=SKERLJ%2C+Renato&rft.inventor=MAKINO%2C+Elina&rft.inventor=METZ%2C+Markus&rft.inventor=NATOLI%2C+Thomas&rft.inventor=GOOD%2C+Andrew&rft.inventor=CABRERA-SALAZAR%2C+Mario%2C+A&rft.inventor=HIRTH%2C+Bradford&rft.inventor=CHENG%2C+Seng%2C+H&rft.inventor=SCHEULE%2C+Ronald%2C+K&rft.inventor=HUSSON%2C+Herve&rft.inventor=MARSHALL%2C+John&rft.inventor=ZHAO%2C+Zhong&rft.inventor=JANCSICS%2C+Katherine&rft.date=2022-02-23&rft.externalDBID=B1&rft.externalDocID=EP2895484B1 |